Gregory Hanson, MD
Urology · Fridley, MNNPI 1699881748
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.8%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Procept Biorobotics Corporation at 47.9% of the total.
Across 87 payments — averaging $75.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$3K
- Gyrus ACMI, Inc.$1K
- Medivators Inc.$500
- Astellas Pharma US Inc$239
- Angiodynamics, Inc.$174
- Intuitive Surgical$144
- plus $1K from 24 others
What the payments were for
- Consulting fees$1,10017%
- Speaking & faculty fees$5008%
- Travel & lodging$2,45037%
- Food & beverage$2,47338%
- Gifts$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 20 | $3,131 |
| Gyrus ACMI, Inc. | 1 | $1,100 |
| Medivators Inc. | 1 | $500 |
| Astellas Pharma US Inc | 7 | $239 |
| Angiodynamics, Inc. | 3 | $174 |
| Intuitive Surgical | 2 | $144 |
| Calyxo, Inc. | 1 | $139 |
| Merck | 7 | $118 |
| Johnson & Johnson(2 entities) | 5 | $99 |
| Teleflex LLC | 3 | $98 |
| Accord Healthcare, Inc. | 5 | $89 |
| Dendreon Pharmaceuticals LLC | 3 | $81 |
| 180 Medical, Inc. | 3 | $75 |
| Cook Medical LLC | 4 | $73 |
| Boston Scientific | 2 | $71 |
| Tempus AI, Inc | 2 | $51 |
| Olympus America Inc. | 2 | $47 |
| SRS Medical Systems, Inc. | 1 | $40 |
| Coloplast | 2 | $38 |
| Urogen Pharma, Inc. | 2 | $37 |
| Blue Earth Diagnostics | 2 | $31 |
| Axonics, Inc. | 1 | $25 |
| Bayer | 1 | $23 |
| Sanofi | 1 | $21 |
| Convatec Inc. | 1 | $21 |
| Photocure Inc | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Caris MPI, Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| ABC Home Medical Supply, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$1,622
- AQUABEAM SYSTEM$872
- CVAC Aspiration System$139
- PADCEV$115
- Nanoknife$108
- Da Vinci Surgical System$104
How this compares
$6,539 in reported general payments places this provider in the 85th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 82 | $1,061,447 |
| OrgovyxRelugolix | 134 | $333,402 |
| ErleadaApalutamide | 16 | $211,021 |
| MyrbetriqMirabegron | 129 | $124,004 |
| Abiraterone Acetate | 60 | $53,590 |
| GemtesaVibegron | 29 | $24,481 |
| Tamsulosin Hcl | 708 | $11,412 |
| Dutasteride | 144 | $4,822 |
| Finasteride | 173 | $3,213 |
| Trospium Chloride ErTrospium Chloride | 11 | $2,333 |
| Solifenacin Succinate | 50 | $2,225 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 86 | $2,158 |
| Tolterodine Tartrate ErTolterodine Tartrate | 18 | $1,735 |
| Oxybutynin Chloride ErOxybutynin Chloride | 92 | $1,721 |
| Potassium Citrate ErPotassium Citrate | 29 | $1,380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $239 | $1,185,451211 claims |
| Johnson & JohnsonErleada | $99 | $211,02116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 247 urology providers in Minnesota.
Other urology in Fridley
- Joseph AkornorFridley$5K
- David YangMankato$298K
- Steven BernsteinEdina$271K
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Jonathan WarnerRochester$144K
- Steven SiegelWoodbury$140K
- Aaron MilbankWoodbury$97K
- Tobias KohlerRochester$89K
- Joseph MahonEdina$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.